EFFECT filed Aug 11, 2026 at 00:15 ET
Lifeward Ltd.'s S-3 shelf registration (File No. 333-297919) became effective on August 10, 2026. This allows the company to sell up to 7,256,474 ordinary shares held by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP, representing approximately 261% of current shares outstanding. The company receives no proceeds from this resale shelf, and the massive potential overhang combined with the auditor's going-concern doubt creates a bearish overhang on the stock.